Voyager Therapeutics (VYGR) Current Deferred Revenue (2015 - 2026)
Voyager Therapeutics (VYGR) reported Current Deferred Revenue of $244,000 for Q2 2026, down 98.8% from $20.52 million a year earlier and down 38.2% from the prior quarter.
Voyager Therapeutics (VYGR) Current Deferred Revenue (2015 - 2026) Analysis & Trends
At the end of FY2025, Voyager Therapeutics posted Current Deferred Revenue of $1.59 million, down 93.5% from FY2024.
- Current Deferred Revenue has declined for three consecutive years, with a five-year compound annual growth rate of -27.1% (FY2020 to FY2025).
- By year, Current Deferred Revenue came in at $24.39 million in FY2024 (-43.1%), $42.88 million in FY2023 (-27.8%), $59.38 million in FY2022 (+75.2%) and $33.89 million in FY2021 (+338.4%).
- The Q2 2026 figure ranks as the lowest quarterly Current Deferred Revenue in data going back to Q3 2015.
- Year over year, Current Deferred Revenue has now declined in each of the last four quarters, with an average decline of 61.8% over the last eight quarters.
- The high point for year-over-year Current Deferred Revenue in five years was Q2 2022 (growth of 978.2%); the low point was Q2 2026 (a decline of 98.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $395,000 (Q1 2026), $1.59 million (Q4 2025) and $10.58 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Voyager Therapeutics | 161.76 Mn | -501.43 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 244,000.00 |
| Mar 31, 2026 | 395,000.00 |
| Dec 31, 2025 | 1.59 Mn |
| Sep 30, 2025 | 10.58 Mn |
| Jun 30, 2025 | 20.52 Mn |
| Mar 31, 2025 | 21.10 Mn |
| Dec 31, 2024 | 24.39 Mn |
| Sep 30, 2024 | 22.63 Mn |
| Jun 30, 2024 | 20.52 Mn |
| Mar 31, 2024 | 51.44 Mn |
| Dec 31, 2023 | 42.88 Mn |
| Sep 30, 2023 | 44.26 Mn |
| Jun 30, 2023 | 31.67 Mn |
| Mar 31, 2023 | 5.68 Mn |
| Dec 31, 2022 | 59.38 Mn |
| Sep 30, 2022 | 56.63 Mn |
| Jun 30, 2022 | 87.00 Mn |
| Mar 31, 2022 | 86.99 Mn |
| Dec 31, 2021 | 33.89 Mn |
| Sep 30, 2021 | 9.54 Mn |
Voyager Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=VYGR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "VYGR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=VYGR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();